CYSLTR1 and lung cancer: Lukic et al., demonstrated that exosomes prepared from lung cancer patient pleura exudates promoted the migration of both A549 lung cancer cells and primary lung cancer cells via CysLTs, whereas the CysLT1R antagonist montelukast blocked this migration [52].